Plante Moran Financial Advisors’s Puma Biotechnology PBYI Stock Holding History

Plante Moran Financial Advisors’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,000	Closed	-$59K	–	827
2018 Q2	$59K	Buy	1,000 +600	+150%	+$34.8K	0.03%	300
2018 Q1	$27K	Sell	400 -100	-20%	-$7.49K	0.01%	456
2017 Q4	$49K	Hold	500	–	–	0.03%	352
2017 Q3	$60K	Sell	500 -500	-50%	-$46.5K	0.04%	270
2017 Q2	$87K	Sell	1,000 -500	-33%	-$28K	0.05%	222
2017 Q1	$56K	Buy	1,500 +1,000	+200%	+$36.5K	0.03%	296
2016 Q4	$15K	Sell	500 -300	-38%	-$13K	0.01%	523
2016 Q3	$54K	Sell	800 -700	-47%	-$35.4K	0.04%	301
2016 Q2	$45K	Buy	+1,500	New	+$46.9K	0.03%	305

Other funds holding PBYI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Plante Moran Financial Advisors's PBYI Position: Q3 2018 in Review

Plante Moran Financial Advisors sold out of Puma Biotechnology (PBYI) in Q3 2018, closing a stake of 1,000 shares — an estimated $59K sold.

Plante Moran Financial Advisors first reported a position in PBYI in Q2 2016 and held it in 9 quarters. The position peaked at $87K in Q2 2017. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2018.

Plante Moran Financial Advisors reported no remaining Puma Biotechnology position as of Q3 2018 after selling out during the quarter.
Plante Moran Financial Advisors sold 1,000 Puma Biotechnology shares in Q3 2018, an estimated $59K.
Plante Moran Financial Advisors first reported a position in Puma Biotechnology in Q2 2016 and held it in 9 quarters.
Plante Moran Financial Advisors's Puma Biotechnology position peaked at $87K in Q2 2017.
156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2018.

Based on Plante Moran Financial Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.